ＡｌｐｈａＮａｖｉ Ｐｈａｒｍａ株式会社
Osaka, Japan
Active| Registration number | T9130001063842 |
|---|---|
| Type | Corporation |
| Registered name | ＡｌｐｈａＮａｖｉ Ｐｈａｒｍａ株式会社 |
| Address | 大阪府吹田市江の木町３３番９４号 33-94 Enokicho, Suita-shi, Osaka 564-0053, JAPAN |
| Corporate number | 9130001063842 |
| Corporate number assigned on | 2019-02-01 |
| Invoice registered on | 2023-10-01 |
The invoice registration date is when the qualified-invoice-issuer registration (T-number) took effect — it is not the date the company was founded, and it resets only if the business re-registers after revocation or expiry.
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Reading (furigana) | アルファナビファーマ |
| Reading (romaji) | Arufanabifama |
| English name (unofficial) | AlphaNavi Pharma K.K. |
| Postal code | 564-0053 |
Source: NTA Corporate Number Publication Site, refreshed daily.
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2024–2024; total ¥0).
| 2024 FY2023 | 国立研究開発法人日本医療研究開発機構出資に必要な経費 ¥0 （内閣府） 国立研究開発法人日本医療研究開発機構より委託を受け、大学等の革新的技術を用いた企業等が行う実用化開発等を実施。優れた課題を採択するため公募を実施し、順次課題を採択することとしている |
|---|
Contract details (excerpt): 家族性小児四肢疼痛発作症に対する新規治療薬の研究開発 ¥0・随意契約（企画競争） · bidders 0
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
Doing due diligence on this supplier?
Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t9130001063842) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-23.
Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence